James H Lewis
#180,346
Most Influential Person Now
Researcher
James H Lewis's AcademicInfluence.com Rankings
James H Lewisengineering Degrees
Engineering
#8386
World Rank
#9920
Historical Rank
Electrical Engineering
#2627
World Rank
#2760
Historical Rank
James H Lewiscomputer-science Degrees
Computer Science
#11363
World Rank
#12034
Historical Rank
Computational Linguistics
#2866
World Rank
#2899
Historical Rank
Machine Learning
#5200
World Rank
#5266
Historical Rank
Artificial Intelligence
#5609
World Rank
#5691
Historical Rank
Download Badge
Engineering Computer Science
James H Lewis's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is James H Lewis Influential?
(Suggest an Edit or Addition)James H Lewis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial (2007) (292)
- Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients (1989) (234)
- Hepatic Findings in Long-Term Clinical Trials of Ximelagatran (2005) (195)
- Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database (2015) (145)
- High-resolution chromoendoscopy for classifying colonic polyps: a multicenter study. (2002) (142)
- The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. (2004) (129)
- Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. (2007) (118)
- Ticrynafen‐Associated Hepatic Injury: Analysis of 340 Cases (1984) (112)
- Drug-induced liver injury in 2007 (2008) (102)
- Drug- and chemical-induced cholestasis. (2004) (99)
- Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature (2016) (87)
- Valproate‐induced hepatic steatogenesis in rats (1982) (86)
- Drug-induced liver disease (2002) (83)
- Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review (2016) (76)
- The rational use of potentially hepatotoxic medications in patients with underlying liver disease (2002) (73)
- ‘Hy's law,’ the ‘Rezulin Rule,’ and other predictors of severe drug‐induced hepatotoxicity: putting risk‐benefit into perspective (2006) (70)
- Drug-Induced Liver Injury: Highlights of the Recent Literature (2018) (70)
- Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time? (2007) (70)
- Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies (2019) (63)
- Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis (2015) (62)
- Turcot's syndrome evidence for autosomal dominant inheritance (1983) (62)
- Hepatotoxicity of Agents Used in the Management of Inflammatory Bowel Disease (2010) (62)
- Drug-induced liver injury: a summary of recent advances (2011) (55)
- Drug-induced liver injury: what was new in 2008? (2009) (55)
- The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. (2015) (54)
- Rheumatologists' awareness of and screening practices for Hepatitis B virus infection prior to initiating immunomodulatory therapy (2010) (49)
- Drug-induced liver disease in 2006 (2007) (45)
- Oncologists and Hepatitis B: A Survey to Determine Current Level of Awareness and Practice of Antiviral Prophylaxis to Prevent Reactivation (2008) (41)
- Hepatotoxicity of antibiotics: a review and update for the clinician. (2013) (37)
- Drug-induced liver disease 2004 (2005) (36)
- The Risk of Ischaemic Colitis in Irritable Bowel Syndrome Patients Treated with Serotonergic Therapies (2011) (35)
- Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice? (2017) (32)
- Drug-Induced Liver Injury in the Elderly (2012) (32)
- 13 – Hepatic injury due to drugs, herbal compounds, chemicals and toxins (2012) (30)
- Current Perspectives in Hepatology (2012) (30)
- Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials (2014) (29)
- Hypoxic hepatitis — its biochemical profile, causes and risk factors of mortality in critically‐ill patients: A cohort study of 565 patients (2017) (29)
- Terbinafine-Induced Acute Autoimmune Hepatitis in the Setting of Hepatitis B Virus Infection (2007) (28)
- NSAID-INDUCED HEPATOTOXICITY (1998) (27)
- Predicting and preventing acute drug-induced liver injury: what's new in 2010? (2010) (26)
- Management of drug-induced liver disease (2001) (25)
- Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective (2010) (24)
- Clinical Perspective: Statins and the Liver—Harmful or Helpful? (2012) (24)
- Latest advances in predicting DILI in human subjects: focus on biomarkers (2012) (24)
- Pancreatic tuberculosis diagnosed with endoscopic ultrasound guided fine needle aspiration. (2005) (23)
- Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. (2020) (23)
- Budd-Chiari syndrome associated with oral contraceptive steroids (1983) (22)
- Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS) (2015) (21)
- Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis (2019) (21)
- Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist (2013) (20)
- Sumatriptan-Associated Ischemic Colitis: Case report and Review of the Literature and FAERS (2014) (20)
- Dermatologists’ Awareness of and Screening Practices for Hepatitis B Virus Infection Before Initiating Tumor Necrosis Factor-&agr; Inhibitor Therapy (2011) (19)
- Use of endoclips to obliterate a colonic arteriovenous malformation before cauterization. (2006) (17)
- Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors (2020) (16)
- Fatal Varicella-Zoster Hepatitis Presenting with Severe Abdominal Pain: A Case Report and Review of the Literature (2006) (16)
- Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic. (2005) (15)
- Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature (2021) (15)
- Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD (2020) (15)
- The adaptive response (drug tolerance) helps to prevent drug-induced liver injury. (2012) (14)
- African Americans May Differ in Their Reasons for Declining Hepatitis C Therapy Compared to Non-African Americans (2009) (14)
- Autoimmune Hepatitis and Thyroiditis Associated with Rifampin and Pyrazinamide Prophylaxis: An Unusual Reaction (2005) (13)
- Percutaneous Liver Biopsy (2004) (13)
- Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease (2019) (13)
- Tuberculosis of the Liver, Biliary Tract, and Pancreas. (2017) (12)
- Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis (2011) (11)
- Drug-induced liver disease (1990) (11)
- Nonsteroidal antiinflammatory drugs and leukotriene receptor antagonists (2013) (11)
- Drug-induced liver injury: what was new in 2013? (2014) (11)
- Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis (2020) (11)
- Significant Variation in the Detection Rates of Proximal Serrated Polyps Among Academic Gastroenterologists, Community Gastroenterologists, and Colorectal Surgeons in a Single Tertiary Care Center (2019) (10)
- Polypharmacy and Comorbidity Are Associated with a Lower Early Virologic Response in Hepatitis C Patients Treated with First Generation Protease Inhibitor Triple Therapy: A Preliminary Analysis (2013) (10)
- Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders (1991) (10)
- Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring. (2010) (9)
- Drug-induced liver injury, dosage, and drug disposition: is idiosyncrasy really unpredictable? (2014) (9)
- Drug-induced liver disease in 2003 (2004) (9)
- Liver Disease Caused by Anesthetics, Toxins, and Herbal Preparations (2010) (9)
- Herbal and dietary supplement induced liver injury: Highlights from the recent literature (2021) (9)
- Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity (2020) (9)
- Safety profile of long‐term H2‐antagonist therapy (1991) (8)
- Tuberculosis of the Liver and Biliary Tract (1988) (8)
- A Pharmacologic approach to gastrointestinal disorders (1994) (8)
- Decision tree for chemical detection applications (1985) (8)
- Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study (2021) (8)
- Nonacetaminophen Drug-Induced Acute Liver Failure. (2018) (7)
- Latest advances in diagnosing and predicting DILI: what was new in 2017? (2018) (7)
- Gastric antral webs in adults: A case series characterizing their clinical presentation and management in the modern endoscopic era (2017) (7)
- Did this drug cause my patient's hepatitis? (2003) (7)
- Pexidartinib long-term hepatic safety profile in TGCT patients. (2020) (7)
- Positive Hemoccult reactions after oral iron: True or false? (1983) (6)
- High-resolution colonoscopy and chromoendoscopy for classifying colonic polyps: Final results of a multicenter study (1998) (6)
- Case of acute mixed liver injury due to hypothyroidism (2018) (6)
- The Effect of the Garren-Edwards Gastric Bubble on Solid and Liquid Gastric Emptying (1988) (5)
- Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update (2020) (5)
- Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials. (2022) (5)
- Licorice for hepatitis C: yum-yum or just ho-hum? (2001) (5)
- Relationship between certain medications and cirrhosis. (2007) (5)
- High resolution chromo-endoscopy: An affordable and accurate non-biopsy technique for predicting histology of colorectal polyps (1996) (5)
- Intron-A plus Ribavirin (Rebetron) for the treatment of chronic hepatitis C in prior interferon monotherapy relapsers (RLPs): Final results of the Washington, DC metropolitan area hepatitis C investigators study (2000) (4)
- Drug-Induced and Toxic Liver Disease (2018) (4)
- Risk/Benefit Assessment of New Drugs: Perspectives of a Former FDA Advisory Committee Member (1993) (4)
- Pexidartinib (Pex) for locally advanced tenosynovial giant cell tumour (TGCT): Characterization of hepatic adverse reactions (ARs) (2019) (4)
- Current Perspectives In Hepatology Festschrift For Hyman J Zimmerman M D (1989) (3)
- Hepatobiliary scanning in hemobilia-induced acute cholecystitis (2005) (3)
- Does race predict outcome in Intron-A plus Ribavirin (Rebetron) for the treatment of chronic hepatitis C in prior interferon monotherapy non-responders (NRs)? Results of the Washington, DC metropolitan area hepatitis C investigators study (2000) (3)
- The Safety of Same-Day Endoscopy and Percutaneous Liver Biopsy (2011) (3)
- Current Clinical Topics in Gastrointestinal Pharmacology (1997) (2)
- Is the Lipid Reduction Seen with High-Dose Pravastatin (Prava) Associated with a Fall in ALT Values in Hypercholesterolemic Pts with NAFLD? Results from a Prospective, Randomized Double-Blind, Placebo (PBO)-Controlled Trial: 346 (2006) (2)
- Do diverticular disease (DD) and/or prior abdominal or pelvic surgery (PAPS) influence the ability to perform complete colonoscopy (CC): A prospective study (1996) (2)
- Prescribing a Statin to a Cirrhotic Patient to Reduce Hepatic Decompensation and Improve Survival: Impossible You Say? (2014) (2)
- The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman (2020) (2)
- How the FDA Handles GI Drug Safety (2012) (2)
- Highlights of the drug-induced liver injury literature for 2021 (2022) (2)
- 699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results (2019) (2)
- Tu1001 - Significant Variation in the Detection Rates of Proximal Serrated Polyps Among Academic Gastroenterologists, Community Gastroenterologists and Colorectal Surgeons in a Single Tertiary Care Center (2018) (2)
- Hepatitis B Reactivation in the Setting of Chemotherapy and Immunosuppression (2009) (2)
- Tu1467 - DILI Publications: Are Authors following the Rules for Causality Assessment? (2018) (1)
- Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology (2022) (1)
- Pyrazinamide/rifampin induced acute autoimmune hepatits and thyroiditis: an unusual reaction (2003) (1)
- 40. Granulomas of the Liver (2011) (1)
- Digitizing DILI: Who can? RUCAM? RECAM? (2022) (1)
- The impact of Endoscopic Ultrasonography (EUS) on the management of patients with gastric lesions diagnosed by other methods (1995) (1)
- Acute Drug-Induced Hepatic Injury (1989) (1)
- H2 antagonists and blood alcohol levels (2005) (1)
- Re: Anderson et al.--Women, BMI, and colonoscopy. (2001) (1)
- Letter: antibiotic dose adjustment in patients with advanced liver disease – authors' reply (2013) (1)
- Timeline of Linkage to Care in Hepatitis C: From Screening to Treatment in the Outpatient Setting at a Tertiary Care Center (2018) (1)
- Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis (2022) (1)
- Mo1329 GASTRIC PORTAL HYPERPLASTIC POLYPS: A POLYPOID VARIANT OF GAVE IN PORTAL HYPERTENSION (2019) (1)
- Su1041 Autoimmune Hepatitis and Chronic Hepatitis C: An Overlooked Overlap Syndrome (2014) (0)
- Response to Borislow and Davis (1989) (0)
- High resolution chromo-endoscopy for the diagnosis of diminutive colon polyps: Implications for colon cancer screening (1995) (0)
- Linkage to Care in Outpatient HCV Testing at an Urban Tertiary Care Medical Center: 1003 (2017) (0)
- Drug-induced liver disease. (2003) (0)
- EditorialLicorice for hepatitis C: yum-yum or just ho-hum? (2001) (0)
- Chronic Lymphocytic Leukemia Involving the Liver Without High-Grade Transformation (2022) (0)
- Tu1029 Superiority of Split-Dose Bowel Preparations (SPLIT) for Morning and Afternoon Colonoscopies: A Single University Hospital Experience (2016) (0)
- Erratum: 'Abdominal pain in hereditary angioedema: The role of hypersecretion' (Am. J. Gastroenterol. 84: 873-877, 1989) (1990) (0)
- Fatal fulminant varicella hepatitis presenting as acute abdominal pain (2003) (0)
- Book reviews (2005) (0)
- 3350 The complication rate of duodenal polypectomy. (2000) (0)
- Liver Histology in Patients That Pursue Expectant Management of Chronic Hepatitis C: Correlating Genotype and Histology with Patientsʼ Decisions (2006) (0)
- Efficacy of Midodrine, Octreotide and Albumin (MOA) for Type I Hepatorenal Syndrome (HRS 1) (2011) (0)
- Miscellaneous Upper Gastrointestinal Symptoms (2016) (0)
- M1082 Safety and Efficacy of Same Day Endoscopy (SDE) Combined With Percutaneous Liver Biopsy (PLB) (2010) (0)
- Tu1004 Enoxaparin Associated Hepatic Events: a Review of the United States Food and Drug Administration Adverse Event Reporting System (FAERS) (2015) (0)
- Drug-induced liver injury: risk factors and drug development in DILI (2021) (0)
- Adult hypertrophic pyloric stenosis (AHPS) after orthotopic liver transplantation (OLT): an unusual occurrence (2001) (0)
- Tu1636 HYPOXIC HEPATITIS IS UNDERRECOGNIZED AND UNDERDIAGNOSED IN THE ICU (2020) (0)
- Defining the Clinical and Biochemical Course of Ischemic Hepatitis in a Large ICU Patient Population With and Without Sepsis: 761 (2016) (0)
- Sa1043 Polypharmacy Is a Risk Factor for Lower Rapid Virological Response Rates Using First Generation Protease Inhibitor Triple Therapy Regimens for Chronic Hepatitis C (2013) (0)
- Gastrointestinal Mucosal Biopsy (1996) (0)
- Demographics, Liver Function, and Source of Hepatitis C Virus Infection in Patients That Decline Interferon Treatment: 393 (2006) (0)
- Clinical utility of video small bowel enteroscopy (1995) (0)
- RANITIDINE PHARMACOKINETICS AND CENTRAL NERVOUS SYSTEM. AUTHORS' REPLY (1994) (0)
- Reasons Why Patients Choose Expectant Management in CHC Infection and Changes in Satisfaction over Time: 254 (2005) (0)
- Su1038 - Knowledge and Attitudes of Trainees' Co-Prescribing Patterns of Gastroprotective Agents in Patients Taking Long-Term Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) (2018) (0)
- High-resolution colonoscopy and chromoendoscopy for classifying colonic polyps: A multicenter study (1997) (0)
- Sa1487 THE ETIOLOGY OF ELEVATED AMINOTRANSFERASES IN THE ICU AND THEIR EFFECT ON MORTALITY (2020) (0)
- Re: Anderson et al.—women, BMI, and Colonoscopy (2001) (0)
- Disorders of the Liver Excluding Hepatitis A, B, C, D, and E (2019) (0)
- Tu1284: THE TREND OF NOVEL FDA DRUGS AND THE OCCURENCE OF DRUG INDUCED LIVER INJURY (2022) (0)
- W1812 Rheumatologists Awareness and General Practice in Screening for Hepatitis B Virus (HBV) Infection Prior to Initiating Immunomodulating Therapies (2009) (0)
- Hepatitis B (HBV) Patients Undergoing Chemotherapy: Who Gets Screened and What Prophylaxis Is Given? A Questionnaire Survey of Oncologists: 281 (2007) (0)
- Drug-induced liver disease: an update for 2010 (2011) (0)
- S3072 Liver Injury Caused by a Weight Loss Supplement Containing Green Tea Extract and Garcinia Cambogia (2022) (0)
- The Role of a Gastroenterologist in Detection of a Hypopharyngeal Cancer: A Case Report: 1802 (2017) (0)
- Tu1322: PHASE 1 STUDY TO TEST SAFETY AND DOSE OF A CHOLECYSTOKININ RECEPTOR ANTAGONIST, PROGLUMIDE, IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) (2022) (0)
- Tumor-Like Hepatic Areas on Imaging in Acute Alcoholic Hepatitis: A Case Series of 5 Patients: 2279 (2017) (0)
- The Emergency Department as an Under-Utilized Clinical Setting for HCV Screening: 6-Year Results at an Urban Tertiary Care Medical Center: 1148 (2017) (0)
- Benefits of Incorporating Serial FibroScan Scores to Manage NALFD Patients Being Treated With Lifestyle Modifications: 895 (2017) (0)
- Tu1037 How Bad Was That Bowel Prep? Results of a Patient Questionnaire Survey at a University Center (2016) (0)
- S2623 Chronic Lymphoid Leukemia With Extensive Liver Infiltration in the Absence of Leukemic Transformation (2021) (0)
- Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist (2013) (0)
- Comparison of Four Different Colonic Preps in 3595 Patients at a University Center: A Real Life Experience (2016) (0)
- AFRICAN AMERICAN (AA) SUSTAINED VIRAL RESPONSE (SVR) TO PEGYLATED INTERFERON + RIBAVARIN (PEG+RBV) IS SIMILAR TO OTHER RACIAL GROUPS WITH CHRONIC HCV GENOTYPE 1. RESULTS FROM AN OPEN ACCESS TREATMENT PROGRAM: 221 (2004) (0)
- Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study (2021) (0)
- Does the type of colonoscope affect the ability to perform complete colonoscopy (1995) (0)
- Reasons Why Patients Choose Expectant Management in Chronic Hepatitis C (CHC) Infection and Changes in Satisfaction over Time.: GAST-2. (2006) (0)
- The role of endoscopy in the evaluation and management of gastrointestinal symptoms in post bone marrow transplant patients (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James H Lewis?
James H Lewis is affiliated with the following schools:
